WOLFGANG WINKELMAYER to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications WOLFGANG WINKELMAYER has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
1.176
-
Statin use and hip fractures in U.S. kidney transplant recipients. BMC Nephrol. 2017 May 01; 18(1):145.
Score: 0.343
-
Impact of reimbursement changes on statin use among patients with diabetes in Austria. Wien Klin Wochenschr. 2010 Feb; 122(3-4):89-94.
Score: 0.207
-
Statins in elderly patients with acute coronary syndrome: an analysis of dose and class effects in typical practice. Heart. 2007 Aug; 93(8):945-51.
Score: 0.170
-
Association between intensity of statin therapy and mortality in persons with chronic kidney disease. Nephrol Dial Transplant. 2020 02 01; 35(2):312-319.
Score: 0.104
-
Preoperative statin use and postoperative acute kidney injury. Am J Med. 2012 Dec; 125(12):1195-1204.e3.
Score: 0.062
-
Kidney function and long-term medication adherence after myocardial infarction in the elderly. Clin J Am Soc Nephrol. 2011 Apr; 6(4):864-9.
Score: 0.055
-
HMG-CoA reductase inhibitors in kidney transplant recipients receiving tacrolimus: statins not associated with improved patient or graft survival. BMC Nephrol. 2010 Apr 01; 11:5.
Score: 0.052
-
Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients. Pharmacoepidemiol Drug Saf. 2008 Dec; 17(12):1189-96.
Score: 0.048
-
Associations of kidney function with cardiovascular medication use after myocardial infarction. Clin J Am Soc Nephrol. 2008 Sep; 3(5):1415-22.
Score: 0.047
-
Use of recommended medications after myocardial infarction in Austria. Eur J Epidemiol. 2008; 23(2):153-62.
Score: 0.045
-
Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of age. Am J Cardiol. 2007 Oct 01; 100(7):1061-7.
Score: 0.044